ABOUT NANOMAB
OVERVIEW
NanoMab Technology Limited is a privately held biopharmaceutical company focusing on cancer precision therapies via the development of next generation radiopharmaceuticals.
We are developing medicine for fast and specific delivery of radiation to treat cancer. A therapeutic product is made by a camelid antibody labelled with a radioisotope of therapeutic radiation. This therapeutic product is paired with a diagnosis, using the same antibody vector but labelled with a lower radiation radioisotope for imaging. Our goal is to develop a pipeline of theranostic couple camelid antibodies with our proprietary camelid antibodies platform to address the unmet medical need for cancer patients across the world.
NanoMab Values
We are developing medicine for fast and specific delivery of radiation to treat cancer.
To address the unmet medical need for cancer patients across the world.
Putting the patient first.